Join the Oncology Voice Network. Join for Free

Lack of Gender Equity in Oncology Clinical Trial Advisory Board Membership

Lack of Gender Equity in Oncology Clinical Trial Advisory Board Membership

by Journal of Clinical Oncology (JCO) Podcast

Nov 25^th 2022
23 mins

Share This Article

Shannon Westin, Pamela Kunz, and Rachna Shroff discuss the lack of gender equity on oncology industry advisory boards.

Click for Source

Related Topics

Explore the Ecosystem

You May Also Like

Article

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis

Does biomarker use in oncology improve clinical trial failure risk? A large-scale analysis

Feb 23^rd • 8 mins • read

Article

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Feb 22^nd • 10 mins • read

Podcast

Hiring Managers Beware: Reverse Rejection Explained!

Michael Pietrack

Hiring Managers Beware: Reverse Rejection Explained!

Nov 26^th • 2 mins • listen

Article

The Talent Inflection Point in Pharma and Biotech: A Challenge to Companies — and a Call to Candidates

Jamie Riley

The Talent Inflection Point in Pharma and Biotech: A Challenge to Companies — and a Call to Candidates

Feb 4^th • 7 mins • read

Article

Clinical Educator Oncology Program Improves Adherence by 29%

iNIZIO

Clinical Educator Oncology Program Improves Adherence by 29%

Sep 3^rd • 1 min • read

Article

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

Vanessa Arciero, BS, Seanthel Delos Santos, Liza Koshy

Assessment of Food and Drug Administration- and European Medicines Agency-Approved Systemic Oncology Therapies and Clinically Meaningful Improvements in Quality of Life: A Systematic Review

Feb 11^th • 4 mins • read

Explore OVN

Articles Expert-written insights

Browse Ecosystem Oncology focus areas

OVN Podcast Flagship show

Community Why join OVN